SMA Solar (S92) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
26 Mar, 2026Executive summary
Revenue for fiscal year 2025 was €1,516m, down 0.9% year-over-year, with growth in Large Scale & Project Solutions offset by weaker Home & Business Solutions (HBS) and significant one-off restructuring and transformation expenses.
EBITDA declined to €-65.4m from €-16m in 2024, mainly due to one-off effects and lower HBS sales volume; operating EBITDA before one-time items was €106.6m.
Free cash flow improved significantly to €110m from €-184m in 2024, driven by positive operating profits and effective net working capital reduction.
Net income fell to €-181.1m, with EPS at €-5.22, reflecting impairments and restructuring costs.
Order backlog remained stable at €1,352m, with product backlog at €1bn.
Financial highlights
Sales: €1,516m in 2025 vs. €1,530m in 2024.
Gross margin dropped to 8.1% from 16.5% year-over-year, mainly due to lower HBS profitability and one-time items.
EBIT fell to €-188.2m (margin -12.4%), with operating EBIT before one-time items at €54.3m.
Net cash position improved, with financial liabilities reduced by €100m and net cash at €176.4m at year-end.
Inverter output sold increased to 19.9 GW from 19.5 GW year-over-year.
Outlook and guidance
2026 sales guidance: €1,475m–€1,675m; EBITDA guidance: €50m–€180m.
Large Scale sales expected slightly above 2025, but EBIT to be lower due to higher service costs, FX effects, and less capitalized R&D.
HBS sales and EBIT expected above 2025, but HBS still not profitable.
Persistent uncertainty from trade barriers, geopolitical conflicts, and new EEG legislation.
Latest events from SMA Solar
- Large Scale growth offsets Home and C&I declines; cash flow and outlook remain pressured.S92
Q2 20242 Feb 2026 - Sharp sales and earnings drop, major restructuring, but Large Scale segment outperforms.S92
Q3 202414 Jan 2026 - 2024 sales and EBITDA declined, but restructuring aims for recovery and EBIT improvement in 2025.S92
Q4 202424 Dec 2025 - Large Scale growth offset weak Home and C&I, with cautious outlook amid tariff and market risks.S92
Q1 202525 Nov 2025 - Sales and margins fell in H1 2025, but cash flow and restructuring efforts improved outlook.S92
Q2 202523 Nov 2025 - Large Scale growth offset by HBS losses and major restructuring; outlook remains challenging.S92
Q3 202517 Nov 2025 - Revenue and earnings fell sharply in 2024, driving a renewed focus on efficiency and innovation.S92
AGM 2025 Presentation1 Jul 2025